Comment

Comment by drivebycomment

From the article:

> Because the woman was already receiving immunosuppressants for a previous liver transplant,

This makes sense - this was the first trial, so doing this on a person already on immunosuppressants minimizes risk while still validating the basics of if it works at all in the first place.

No comments yet

Be the first to share your thoughts.

Live from the official Hacker News API

A modern reader for Hacker News · SvelteKit + Skeleton